Growth Hormone Market Research Report - Global Forecast till 2027

Growth hormone Market Research Report: Information By Brand (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Others), By Application (Growth Hormone Deficiency, Idiopathic, Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others), By Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites) - Global Forecast till 2027

ID: MRFR/HC/5032-CR | February, 2021 | Region : Global

Market Overview


Growth Hormone Market size can touch 7.50% from 2018 to 2023 (evaluation period), says Market Research Future (MRFR). The global market is strengthened by the surge in initiatives being undertaken by government bodies as well as private firms for raising the awareness level among the mass with regard to GH deficiencies as well as growth hormone treatment could induce significant market growth. Furthermore, Norditropin has emerged as one of the top brands in the global human growth hormone market.


COVID-19 Analysis


Following the COVID-19 outbreak, the focus has shifted towards accelerated production of affordable and effective drugs, with the pandemic shining light on healthcare inequities. For accelerated drug development rate, the demand for real-world evidence has soared considerably, with major companies now opting for remote monitoring as well as source document verification (SDV), ensuring that patients are able to benefit despite the novel coronavirus and the resultant lockdown. While SARS-CoV-2 occupies healthcare’s attention, growth hormone deficiency continues to be one of the key focus areas across the globe. Therefore, studies are in progress to understand the importance of growth hormone drugs and foster their application scope. Growth in the pediatric growth hormone market size has also been favorable, in the post-pandemic era.


Market Dynamics


Surge in GH Deficiency Cases to be a Key Growth Booster


Growth hormone deficiency has become a huge burden for the healthcare industry, and the most common reason for the same is considered to be brain injury. This condition is marked with a host of symptoms, such as reduced energy levels, altered body composition, lower muscle strength, insulin resistance, osteoporosis and lipid abnormalities that include high LDL cholesterol and more. In a nutshell, the growth hormone market share is expected to be bolstered by the rising GH deficiency disorders worldwide.


Opportunities


Surge in FDA Approvals to Offer Lucrative Opportunities


Accelerated use of growth hormones for conditions like Turner syndrome, small for gestational age and idiopathic short stature can be a major growth hormone market trend in the following years. The escalation in growth hormone deficiency disorders across countries is proving to be favorable for players, encouraging them to introduce more advances in the growth hormone therapy. The surge in FDA approvals is also presenting a host of opportunities to the players to develop novel drugs that are more effective, and have lower side effects.


Restraints


Side Effects of GH Drugs to Weaken Demand


Growth hormone therapies remain the standard line of treatment for the deficiency but side effects like joint pain, fluid retention and muscle pain associated with synthetic growth hormones can go on to become one of the key deterrents in the market growth, in the ensuing years.


Challenges


High Costs of GH Therapies Deter Patients from Seeking Treatment


The market can face challenges in the form of expensive GH therapy costs, which deter patients from seeking treatment. However, firms are bolstering product pipelines and also focusing on rigorous research and development (R&D) activities for producing more cost effective human growth hormone for sale as well as effective therapies that can ensure steady demand.


Cumulative Growth Analysis


Increased Spending by Firms and Government Support to Foster Growth


The MRFR hormonal market analysis suggests that various factors will be contribute towards growth, some of which include rising spending by vendors, presence of a robust pipeline, rigorous R&D activities and the soaring number of government initiatives. As a result, the forecast period will witness significant market growth, believes MRFR.


Market Segmentation


Norditropin to be the Leading Brand in the Global Market


The top human growth hormone brands analyzed in the MRFR report are genotropin, norditropin, saizen, omnitrope, humatrope, to list a few. Norditropin has remained the top brand in the worldwide market since 2017 and can exhibit to continue scaling at a robust pace over the appraisal period. Norditropin HGH injections are Novo Nordisk’s offering and are one of the most popular human growth hormone brands that are premixed as well as prefilled.  


Growth Hormone’s Application to be extensive in GH Deficiency Cases


Growth hormones’ primary applications are in idiopathic, growth hormone deficiency, small for gestational age, short stature, prader-willi syndrome, turner syndrome and others. GH deficiency accounts for the biggest share in the global market and can most likely continue leading during the forecast timeline.  


Subcutaneous Route of Administration to Remain at the Top


In terms of the route of administration, the market can be considered for intramuscular, subcutaneous, oral and intravenous. Out of these, subcutaneous can remain the dominant segment throughout the review period, as the growth hormones that are administered subcutaneously are more bioavailable, especially when compared to its counterparts.


Hospital Pharmacy Distribution Channel to take the Lead


With respect to distribution channel, the industry has been split into retail pharmacies, hospital pharmacies, e-commerce websites and clinics. Hospital pharmacy has garnered the biggest share in view of the escalating hospital visits in light of surging awareness regarding GH deficiency and its treatment options among the mass. Additionally, online pharmacy is gaining traction in developed regions like Europe and North America and also in developing nations like India and China.


Regional Analysis


Presence of Well-Known Brands to Ensure Americas’ Dominance


The highest production of human growth hormone for sale is observed in the Americas, which boosts the region’s potential to secure the lead over the coming years. The key growth rendering factors include supportive reimbursement policies, well-developed healthcare infrastructure, significant government efforts and the high awareness level among people. The surging availability of novel drugs backed by the existence of a huge number of renowned firms also benefits the American market. The biggest human growth hormone brands in America are Eli Lilly and Company; Genentech Inc. and Pfizer Inc.; which boast of an extensive range of advanced therapies. These companies are responsible for the strong performance of the growth hormone market US.


Europe to Clinch the Second Place   


The human growth hormone (hgh) market in Europe is dissected into Eastern Europe as well as Western Europe. Western Europe has promising markets such as Germany, France, the UK, Spain and Italy, and these countries will help Europe clinch the second position in the coming years. Europe is a highly profitable market, thanks to the increased burden of growth hormone deficiencies and the rising preference for growth hormones for treating Idiopathic Short Stature (ISS). A prominent growth hormone market trend can be the rising availability of artificial growth hormones, in addition to the extensive R&D activities that benefit the recombinant human growth hormone market.


APAC to Maintain Considerable Growth Rate


Asia Pacific can project considerable growth rate over the evaluation period, since the majority of the firms here are indulging in intense competition to garner a higher share in the regional market. The highest growth potential in the region is demonstrated by Japan and China, with the surge in drug approvals and frequent launch of new products. The overall APAC market also gains from the increasing healthcare spending, penetration of global vendors, rise in disposable income, and more.


Competitive Landscape


Rapid Uptake of Strategies by Players to Bolster Position


A huge number of players are mainly focused on taking up growth strategies that help them bolster their market positions. Some of these strategies include partnerships, collaborations and significant spending on the development of effective and long-acting drugs with low side effects. These players are focused on technical advances in the Human Growth Hormone (HGH) Market to elevate their global presence.


Merck is one of the leading growth hormone vendors, with major focus on science and technology, backed by extensive researches and discoveries. Merck’s popular growth hormone called Saizen, is an autoinjector that has a high-tech system easypod. Company’s modern product portfolio has injection devices and a wireless transmitter as well as associated software. Merck focuses primarily on developing cost effective drugs and devices that facilitate accurate dose administration.


List of Key Companies Covered in this Report



  • Merck KGaA

  • Novartis AG

  • GeneScience Pharmaceuticals Co. Ltd

  • Ipsen S.A.

  • Eli Lily and Company

  • Novo Nordisk A/S

  • Zhongshan Hygene Biopharm Co. Ltd

  • Lifetech Labs

  • Biopartners GmbH

  • Genetech Inc.

  • Pfizer Inc.

  • Anhui Anke Biotechnology (Group) Co. Ltd


Recent Developments



  • In November 2020, GenSci (GenScience Pharmaceuticals), entered an exclusive agreement with Foresee Pharmaceuticals, for commercializing the latter’s FP-001 program, LMIS (Leuprolide Mesylate Injectable Suspension) –subcutaneous, ready-to-use 3-month and 6-month depot formulations or Camcevi. This agreement will be solely focusing on the Chinese market.



  • November 2020, Aeterna collaborated with Novo Nordisk, with the aim to boost the application scope of macimorelin that helps diagnose growth hormone deficiency, which is childhood-onset. The company believes that this area is considerably untapped and therefore, desires to explore the unmet needs. Aeterna is currently in the early stage of clinical safety as well as efficacy study, which focuses on analyzing Macimorelin for detection of CGHD.


Report Overview


Scope of the Report


The MRFR report highlights the growth boosters and barriers in the global market for growth hormone. The report has thrown light on the COVID-19 impact on the global market, its future progress rate, government’s role in the said growth, surging cases of rate diseases that require growth hormones and also the regions that are emerging as key consumers.


Segmentation Table



  • Key Brands

    • Norditropin

    • Genotropin

    • Humatrope

    • Saizen

    • Omnitrope



  • Applications

    • Growth Hormone Deficiency

    • Idiopathic Short Stature

    • Small for Gestational Age

    • Turner Syndrome

    • Prader-Willi Syndrome



  • Route of Administration

    • Subcutaneous

    • Intramuscular

    • Intravenous

    • Oral



  • Distribution Channel

    • Hospital Pharmacies

    • Retail Pharmacies

    • Clinics

    • E-Commerce Websites



1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 20

3.2 Scope of the Study 20

3.3 Research Objective 20

3.4 Assumptions & Limitations 20

3.4.1 Assumptions 20

3.4.2 Limitations 20

3.4.3 Market Structure 21

4 Research Methodology

4.1 Research Process 23

4.2 Primary Research 24

4.3 Secondary Research 25

4.4 Market Size Estimation 26

4.5 Forecast Model 26

5 Market Dynamics

5.1 Introduction 28

5.2 Drivers 29

5.2.1 Rising cases of growth hormone deficiency 29

5.2.2 Increasing awareness about the endocrine disorders, and effectiveness of growth hormones 29

5.2.3 Widener scope of application of growth hormones 30

5.3 Restraints 30

5.3.1 Side-effects associated with the growth hormone therapy 30

5.3.2 High cost of treatment and lack of health insurance coverage 30

5.4 Opportunities 31

5.4.1 Strong pipeline of hormonal drugs and easy availability of pharma drugs on E-commerce 31

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 33

6.1.1 Bargaining Power of Suppliers 33

6.1.2 Bargaining Power of Buyers 33

6.1.3 Threat of New Entrants 33

6.1.4 Threat of Substitutes 34

6.1.5 Intensity of Rivalry 34

6.2 Supply chain analysis 34

6.2.1 R&D 34

6.2.2 Manufacturing 34

6.2.3 Distribution 35

6.2.4 Marketing & Sales 35

6.2.5 Post-Sales Monitoring 35

6.3 Investment Opportunities 35

7 Growth Hormone Market, by Brand

7.1 Overview 37

7.1.1 Norditropin 38

7.1.2 Genotropin 39

7.1.3 Humatrope 39

7.1.4 Saizen 40

7.1.5 Omnitrope 40

7.1.6 Others 40

8 . Growth Hormone Market, by Application

8.1 Overview 42

8.1.1 Growth Hormone Deficiency 43

8.1.2 Idiopathic Short Stature 44

8.1.3 Small for Gestational Age 44

8.1.4 Turner Syndrome 45

8.1.5 Prader-Willi Syndrome 45

8.1.6 Others 46

9 Growth Hormone Market, by Route of Administration

9.1 Overview 48

9.1.1 Subcutaneous 49

9.1.2 Intramuscular 50

9.1.3 Intravenous 50

9.1.4 Oral 51

10 Growth Hormone Market, by Distribution Channel

10.1 Overview 53

10.1.1 Hospital Pharmacies 54

10.1.2 Retail Pharmacies 54

10.1.3 Clinics 55

10.1.4 E-Commerce Websites 55

11 Global Growth Hormone Market, By Region

11.1 Introduction 57

11.2 Americas 59

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.2.1 North America 61

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.2.1.1 U.S. 63

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.2.1.2 Canada 64

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.2.2 South America 66

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3 Europe 68

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1 Western Europe 70

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1.1 Germany 72

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1.2 France 73

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1.3 U.K 75

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1.4 Italy 76

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1.5 Spain 78

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.1.6 Rest of Western Europe 79

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.3.2 Eastern Europe 81

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4 Asia Pacific 83

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4.1 Japan 85

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4.2 China 87

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4.3 India 88

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4.4 Australia 90

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4.5 Republic of Korea 91

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.4.6 Rest of Asia Pacific 93

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.5 The Middle East & Africa 95

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.5.1 Overview 95

11.6 GCC 98

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.6.1 Saudi Arabia 100

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.6.2 United Arab Emirates 102

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.6.3 Kuwait 103

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.6.4 Qatar 105

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.6.5 Oman 106

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.6.6 Bahrain 108

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7 Middle East 110

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7.1 Egypt 112

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7.2 Jordan 113

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7.3 Lebanon 115

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7.4 Iran 116

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7.5 Iraq 118

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.7.6 Rest of Middle East 119

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.8 Africa 121

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.8.1 South Africa 123

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.8.2 Morocco 124

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.8.3 Algeria 126

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.8.4 Tunisia 127

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

11.8.5 Rest of Africa 129

Growth Hormone Market, by Brand

. Growth Hormone Market, by Application

Growth Hormone Market, by Route of Administration

Growth Hormone Market, by Distribution Channel

12 Competitive Landscape

12.1 Company Market Share Analysis 132

12.2 Key Developments 133

13 Company Profiles

13.1 Novo Nordisk A/S 135

13.1.1 Company Overview 135

13.1.2 Financial Overview 135

13.1.3 Products Offering 136

13.1.4 Key Developments 136

13.1.5 SWOT Analysis 136

13.1.6 Key Strategy 136

13.2 Pfizer Inc. 137

13.2.1 Company Overview 137

13.2.2 Financial Overview 137

13.2.3 Products Offering 138

13.2.4 Key Developments 138

13.2.5 SWOT Analysis 138

13.2.6 Key Strategy 138

13.3 Novartis AG 139

13.3.1 Company Overview 139

13.3.2 Financial Overview 139

13.3.3 Products Offering 140

13.3.4 Key Developments 140

13.3.5 SWOT Analysis 140

13.3.6 Key Strategy 140

13.4 Anhui Anke Biotechnology (Group) Co., Ltd 141

13.4.1 Company Overview 141

13.4.2 Financial Overview 141

13.4.3 Products Offering 141

13.4.4 Key Developments 141

13.4.5 SWOT Analysis 141

13.4.6 Key Strategy 141

13.5 Biopartners GmbH 142

13.5.1 Company Overview 142

13.5.2 Financial Overview 142

13.5.3 Products Offering 143

13.5.4 Key Developments 143

13.5.5 SWOT Analysis 143

13.5.6 Key Strategy 143

13.6 Ipsen S.A. 144

13.6.1 Company Overview 144

13.6.2 Financial Overview 144

13.6.3 Products Offering 145

13.6.4 Key Developments 145

13.6.5 SWOT Analysis 145

13.6.6 Key Strategy 145

13.7 Eli Lily and Company 146

13.7.1 Company Overview 146

13.7.2 Financial Overview 146

13.7.3 Products Offering 147

13.7.4 Key Developments 147

13.7.5 SWOT Analysis 147

13.7.6 Key Strategy 147

13.8 Merck KGaA 148

13.8.1 Company Overview 148

13.8.2 Financial Overview 148

13.8.3 Products Offering 149

13.8.4 Key Developments 149

13.8.5 SWOT Analysis 149

13.8.6 Key Strategy 149

13.9 GeneScience Pharmaceuticals Co., Ltd 150

13.9.1 Company Overview 150

13.9.2 Financial Overview 150

13.9.3 Products Offering 150

13.9.4 Key Developments 150

13.9.5 SWOT Analysis 150

13.9.6 Key Strategy 151

13.10 Lifetech Labs 152

13.10.1 Company Overview 152

13.10.2 Financial Overview 152

13.10.3 Products Offering 152

13.10.4 Key Developments 152

13.10.5 SWOT Analysis 152

13.10.6 Key Strategy 153

13.11 Genetech Inc. 154

13.11.1 Company Overview 154

13.11.2 Financial Overview 154

13.11.3 Products Offering 155

13.11.4 Key Developments 155

13.11.5 SWOT Analysis 155

13.11.6 Key Strategy 155

13.12 Zhongshan Hygene Biopharm Co., Ltd 156

13.12.1 Company Overview 156

13.12.2 Financial Overview 156

13.12.3 Products Offering 156

13.12.4 Key Developments 156

13.12.5 SWOT Analysis 156

13.12.6 Key Strategy 156

14 Appendix

14.1 Discussion Blue Print 158

15 List of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 PRIMARY INTERVIEWS 23

TABLE 3 GLOBAL GROWTH HORMONE MARKET BY BRAND, 2020-2027 (USD MILLION) 38

TABLE 4 GLOBAL GROWTH HORMONE MARKET FOR NORDITROPIN, BY REGION, 2020-2027 (USD MILLION) 38

TABLE 5 GLOBAL GROWTH HORMONE MARKET FOR GENOTROPIN, BY REGION, 2020-2027 (USD MILLION) 39

TABLE 6 GLOBAL GROWTH HORMONE MARKET FOR HUMATROPE, BY REGION, 2020-2027 (USD MILLION) 39

TABLE 7 GLOBAL GROWTH HORMONE MARKET FOR SAIZEN, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 8 GLOBAL GROWTH HORMONE MARKET FOR OMNITROPE, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 9 GLOBAL GROWTH HORMONE MARKET BY APPLICATION, 2020-2027 (USD MILLION) 43

TABLE 10 GLOBAL GROWTH HORMONE MARKET FOR GROWTH HORMONE DEFICIENCY, BY REGION, 2020-2027 (USD MILLION) 43

TABLE 11 GLOBAL GROWTH HORMONE MARKET FOR IDIOPATHIC SHORT STATURE, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 12 GLOBAL GROWTH HORMONE MARKET FOR SMALL FOR GESTATIONAL AGE, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 13 GLOBAL GROWTH HORMONE MARKET FOR TURNER SYNDROME, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 14 GLOBAL GROWTH HORMONE MARKET FOR PRADER-WILLI SYNDROME, BY REGION, 2020-2027 (USD MILLION) 45

TABLE 15 GLOBAL GROWTH HORMONE MARKET BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 49

TABLE 16 GLOBAL GROWTH HORMONE MARKET FOR SUBCUTANEOUS, BY REGION, 2020-2027 (USD MILLION) 49

TABLE 17 GLOBAL GROWTH HORMONE MARKET FOR INTRAMUSCULAR, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 18 GLOBAL GROWTH HORMONE MARKET FOR INTRAVENOUS, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 19 GLOBAL GROWTH HORMONE MARKET FOR ORAL, BY REGION, 2020-2027 (USD MILLION) 51

TABLE 20 GLOBAL GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 53

TABLE 21 GLOBAL GROWTH HORMONE MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 22 GLOBAL GROWTH HORMONE MARKET FOR RETAIL PHARMACIES, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 23 GLOBAL GROWTH HORMONE MARKET FOR CLINICS, BY REGION, 2020-2027 (USD MILLION) 55

TABLE 24 GLOBAL GROWTH HORMONE MARKET FOR E-COMMERCE WEBSITES, BY REGION, 2020-2027 (USD MILLION) 55

TABLE 25 GLOBAL GROWTH HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 57

TABLE 26 AMERICAS: GROWTH HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 59

TABLE 27 AMERICAS GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 60

TABLE 28 AMERICAS GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 60

TABLE 29 AMERICAS GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 60

TABLE 30 AMERICAS GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 61

TABLE 31 NORTH AMERICA: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 61

TABLE 32 NORTH AMERICA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 61

TABLE 33 NORTH AMERICA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 62

TABLE 34 NORTH AMERICA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 62

TABLE 35 NORTH AMERICA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 62

TABLE 36 U.S. GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 63

TABLE 37 U.S. GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 63

TABLE 38 U.S. GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 63

TABLE 39 U.S. GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 64

TABLE 40 CANADA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 64

TABLE 41 CANADA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 64

TABLE 42 CANADA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 65

TABLE 43 CANADA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 65

TABLE 44 SOUTH AMERICA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 66

TABLE 45 SOUTH AMERICA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 66

TABLE 46 SOUTH AMERICA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 66

TABLE 47 SOUTH AMERICA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 67

TABLE 48 EUROPE: GROWTH HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 68

TABLE 49 EUROPE GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 69

TABLE 50 EUROPE GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 69

TABLE 51 EUROPE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 69

TABLE 52 EUROPE GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 70

TABLE 53 WESTERN EUROPE: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 70

TABLE 54 WESTERN EUROPE GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 70

TABLE 55 WESTERN EUROPE GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 71

TABLE 56 WESTERN EUROPE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 71

TABLE 57 WESTERN EUROPE GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 71

TABLE 58 GERMANY GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 72

TABLE 59 GERMANY GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 72

TABLE 60 GERMANY GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 72

TABLE 61 GERMANY GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 73

TABLE 62 FRANCE GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 73

TABLE 63 FRANCE GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 73

TABLE 64 FRANCE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 74

TABLE 65 FRANCE GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 74

TABLE 66 U.K GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 75

TABLE 67 U.K GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 75

TABLE 68 U.K GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 75

TABLE 69 U.K GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 76

TABLE 70 ITALY GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 76

TABLE 71 ITALY GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 76

TABLE 72 ITALY GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 77

TABLE 73 ITALY GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 77

TABLE 74 SPAIN GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 78

TABLE 75 SPAIN GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 78

TABLE 76 SPAIN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 78

TABLE 77 SPAIN GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 79

TABLE 78 REST OF WESTERN EUROPE GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 79

TABLE 79 REST OF WESTERN EUROPE GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 79

TABLE 80 REST OF WESTERN EUROPE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 80

TABLE 81 REST OF WESTERN EUROPE GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 80

TABLE 82 EASTERN EUROPE GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 81

TABLE 83 EASTERN EUROPE GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 81

TABLE 84 EASTERN EUROPE GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 81

TABLE 85 EASTERN EUROPE GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 82

TABLE 86 ASIA PACIFIC: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 83

TABLE 87 ASIA PACIFIC GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 84

TABLE 88 ASIA PACIFIC GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 84

TABLE 89 ASIA PACIFIC GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 84

TABLE 90 ASIA PACIFIC GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 85

TABLE 91 JAPAN GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 85

TABLE 92 JAPAN GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 85

TABLE 93 JAPAN GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 86

TABLE 94 JAPAN GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 86

TABLE 95 CHINA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 87

TABLE 96 CHINA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 87

TABLE 97 CHINA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 87

TABLE 98 CHINA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 88

TABLE 99 INDIA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 88

TABLE 100 INDIA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 88

TABLE 101 INDIA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 89

TABLE 102 INDIA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 89

TABLE 103 AUSTRALIA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 90

TABLE 104 AUSTRALIA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 90

TABLE 105 AUSTRALIA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 90

TABLE 106 AUSTRALIA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 91

TABLE 107 REPUBLIC OF KOREA GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 91

TABLE 108 REPUBLIC OF KOREA GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 91

TABLE 109 REPUBLIC OF KOREA GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 92

TABLE 110 REPUBLIC OF KOREA GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 92

TABLE 111 REST OF ASIA PACIFIC GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 93

TABLE 112 REST OF ASIA PACIFIC GROWTH HORMONE MARKET, BY APPLICATIONS, 2020-2027 (USD MILLION) 93

TABLE 113 REST OF ASIA PACIFIC GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 93

TABLE 114 REST OF ASIA PACIFIC GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 94

TABLE 115 MIDDLE EAST AND AFRICA GROWTH HORMONE MARKET, BY REGION, 2020-2027 (USD MILLION) 96

TABLE 116 MIDDLE EAST AND AFRICA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 96

TABLE 117 MIDDLE EAST AND AFRICA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 96

TABLE 118 MIDDLE EAST AND AFRICA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 97

TABLE 119 MIDDLE EAST AND AFRICA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 97

TABLE 120 GCC: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 98

TABLE 121 GCC: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 99

TABLE 122 GCC: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 99

TABLE 123 GCC: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 99

TABLE 124 GCC: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 100

TABLE 125 SAUDI ARABIA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 100

TABLE 126 SAUDI ARABIA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 100

TABLE 127 SAUDI ARABIA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 101

TABLE 128 SAUDI ARABIA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 101

TABLE 129 UNITED ARAB EMIRATES: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 102

TABLE 130 UNITED ARAB EMIRATES: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 102

TABLE 131 UNITED ARAB EMIRATES: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 102

TABLE 132 UNITED ARAB EMIRATES: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 103

TABLE 133 KUWAIT: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 103

TABLE 134 KUWAIT: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 103

TABLE 135 KUWAIT: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 104

TABLE 136 KUWAIT: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 104

TABLE 137 QATAR: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 105

TABLE 138 QATAR: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105

TABLE 139 QATAR: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 105

TABLE 140 QATAR: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 106

TABLE 141 OMAN: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 106

TABLE 142 OMAN: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 106

TABLE 143 OMAN: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 107

TABLE 144 OMAN: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 107

TABLE 145 BAHRAIN: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 108

TABLE 146 BAHRAIN: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 108

TABLE 147 BAHRAIN: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 108

TABLE 148 BAHRAIN: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 109

TABLE 149 MIDDLE EAST: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 110

TABLE 150 MIDDLE EAST: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 110

TABLE 151 MIDDLE EAST: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 111

TABLE 152 MIDDLE EAST: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 111

TABLE 153 MIDDLE EAST: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 111

TABLE 154 EGYPT: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 112

TABLE 155 EGYPT: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 112

TABLE 156 EGYPT: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 112

TABLE 157 EGYPT: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 113

TABLE 158 JORDAN: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 113

TABLE 159 JORDAN: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 113

TABLE 160 JORDAN: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 114

TABLE 161 JORDAN: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 114

TABLE 162 LEBANON: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 115

TABLE 163 LEBANON: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 115

TABLE 164 LEBANON: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 115

TABLE 165 LEBANON: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 116

TABLE 166 IRAN: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 116

TABLE 167 IRAN: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 116

TABLE 168 IRAN: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 117

TABLE 169 IRAN: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 117

TABLE 170 IRAQ: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 118

TABLE 171 IRAQ: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 118

TABLE 172 IRAQ: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 118

TABLE 173 IRAQ: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 119

TABLE 174 REST OF MIDDLE EAST: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 119

TABLE 175 REST OF MIDDLE EAST: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 119

TABLE 176 REST OF MIDDLE EAST: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 120

TABLE 177 REST OF MIDDLE EAST: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 120

TABLE 178 AFRICA: GROWTH HORMONE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 121

TABLE 179 AFRICA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 121

TABLE 180 AFRICA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 122

TABLE 181 AFRICA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 122

TABLE 182 AFRICA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 122

TABLE 183 SOUTH AFRICA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 123

TABLE 184 SOUTH AFRICA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 123

TABLE 185 SOUTH AFRICA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 123

TABLE 186 SOUTH AFRICA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 124

TABLE 187 MOROCCO: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 124

TABLE 188 MOROCCO: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 124

TABLE 189 MOROCCO: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 125

TABLE 190 MOROCCO: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 125

TABLE 191 ALGERIA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 126

TABLE 192 ALGERIA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 126

TABLE 193 ALGERIA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 126

TABLE 194 ALGERIA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 127

TABLE 195 TUNISIA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 127

TABLE 196 TUNISIA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 128

TABLE 197 TUNISIA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 128

TABLE 198 TUNISIA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 128

TABLE 199 REST OF AFRICA: GROWTH HORMONE MARKET, BY BRAND, 2020-2027 (USD MILLION) 129

TABLE 200 REST OF AFRICA: GROWTH HORMONE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 129

TABLE 201 REST OF AFRICA: GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 129

TABLE 202 REST OF AFRICA: GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION) 130

16 List of Figures

FIGURE 1 RESEARCH PROCESS 23

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL GROWTH HORMONE MARKET 28

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL GROWTH HORMONE MARKET 33

FIGURE 5 SUPPLY CHAIN ANALYSIS OF THE GLOBAL GROWTH HORMONE MARKET 34

FIGURE 6 GLOBAL GROWTH HORMONE MARKET, BY BRAND, 2020 (% SHARE) 37

FIGURE 7 GLOBAL GROWTH HORMONE MARKET, BY BRAND, 2020 & 2027 37

FIGURE 8 GLOBAL GROWTH HORMONE MARKET, BY APPLICATION, 2020 (% SHARE) 42

FIGURE 9 GLOBAL GROWTH HORMONE MARKET, BY APPLICATION, 2020 & 2027 42

FIGURE 10 GLOBAL GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020 (% SHARE) 48

FIGURE 11 GLOBAL GROWTH HORMONE MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2027 48

FIGURE 12 GLOBAL GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020 (% SHARE) 53

FIGURE 13 GLOBAL GROWTH HORMONE MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 53

FIGURE 14 GLOBAL GROWTH HORMONE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 57

FIGURE 15 GLOBAL GROWTH HORMONE MARKET, BY REGION, 2020 (% SHARE) 58

FIGURE 16 AMERICAS: GROWTH HORMONE MARKET SHARE, BY REGION, 2020 (% SHARE) 59

FIGURE 17 EUROPE: GROWTH HORMONE MARKET SHARE, BY REGION, 2020 (%) 68

FIGURE 18 ASIA PACIFIC: GROWTH HORMONE MARKET SHARE, BY COUNTRY, 2020 (%) 83

FIGURE 19 MIDDLE EAST AND AFRICA GROWTH HORMONE MARKET, BY REGION, 2020 (% SHARE) 95

FIGURE 20 GLOBAL GROWTH HORMONE MARKET, MARKET SHARE ANALYSIS 2020 (% SHARE) 132



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Human Growth Hormone Market